Key Takeaways
- A brutal quarter, but the bottom is in: Revenue fell to INR 345 crores and EBITDA turned negative (INR -0.4 crores) as global destocking crushed volumes and pricing. Management declared prices have bottomed out completely across agrochemicals and pigments.
- The recovery bet is on FY25, not Q4: Demand is expected to start improving from Q1 FY25, with price increases following only slowly after that. The next 3-4 months are still about clearing the remaining inventory overhang.
- TiO2 and Nano-Urea are the twin growth pivots: The TiO2 captive power plant commissions in Q4, slashing utility costs, while the Nano-Urea project marks a strategic entry into the domestic crop nutrition and branded B2C space. Both are expected to contribute meaningfully from FY25.
- China is dumping, but India is the structural second source: Chinese producers are keeping prices unsustainably low to drive out competition, but global customers, scarred by post-COVID supply shocks, are prioritizing a China Plus One strategy with India as the preferred alternative.
- What to watch next quarter: Whether the captive power plant commissions on time and delivers the promised TiO2 cost reduction, any early signs of the Q1 demand recovery materializing, and the pace of MPP utilization improvement from its sub-25% trough.
Demand & Pricing Environment
- The destocking cycle is ending, not ended: The last 3-4 years were fantastic for the chemical industry due to COVID supply chain issues. Once supply chains normalized, logistics costs fell, inventory piled up, and rising interest rates caused buyers to stop forward purchasing. Inventory has now started going down drastically, but 3-4 months of excess stock still remains.
- Prices have found a floor: At the manufacturing level, inventory has come down and plants are running at lower capacity without building fresh inventory. Management stated prices have bottomed out completely across agrochemicals and pigments, with no further reduction in pigment selling prices this quarter.
- The Red Sea disruption is a double-edged sword: Logistic time has increased by 25-30 days, forcing customers to buy 25-30 days in advance. This pulls some demand forward, but customers, having been burned by carrying high-price inventory that collapsed in value, remain deeply cautious about rebuilding stock.
- The recovery will be sequential, not sudden: Demand will start improving from Q1 FY25, then slowly prices will go up. From the current bottom, prices should rise at least 5% to 10%, but management cautioned they may never return to pre-COVID levels: "it will take very much long time to go back at the same level or it may not go in the future."
Patel: "Immediate price correction will not happen. Initially the demand will start improving. Once the demand will improve, only after that slowly gradually the price will start going up."
Segment-Level Performance
| Segment | Trend | Commentary |
|---|---|---|
| Agrochemicals (Crop Chem) | ▼ Severe pressure | Synthetic pyrethroid demand under pressure from high consumer inventory and adverse weather; routine consumption still happening. Operating margin moderated because more formulation sales vs technical sales left some technical plants underutilized. |
| Pigments | ▬ Stabilizing | Slight demand improvement has started, particularly in Phthalocyanine-based pigments (green and blue). Pricing more stabilized compared to previous quarters. Company is now changing strategy to serve small domestic customers and expand the basket, a market it previously ignored due to low volume. |
| Titanium Dioxide | ▼ Ramping up | Prices at bottom level. Plant running at 30-40% capacity, expected to reach 70% in two months. Captive power plant commissioning in Q4 will drastically reduce utility costs, the majority cost component. Product quality is set and samples are being given in the market. |
| Nano-Urea | ▲ New entry | Coming under Meghmani Crop Nutrition, marking entry into the nutrition segment and a branded B2C play. IFFCO initially miscommunicated that it can replace Urea completely; the correct message is partial replacement only. Demonstration is the key to farmer adoption. |
- Export-heavy B2B model amplified the pain: Companies more domestic and brand-oriented had less impact. Meghmani was over 85% exports B2B, so it was disproportionately hit. Many export-focused players are now pivoting to the domestic market, but sticking to B2B domestic will pressure margins; the company needs to increase its branding market share to balance the portfolio.
- Overcapacity is self-correcting, slowly: In good times, companies expanded into products even without backward integration. Capacity shutdowns have already started in certain products, and some capacities are shifting to different products as companies realize they cannot continue. Meghmani itself has not expanded into the same old products, instead spending earnings on new product lines, which management says differentiates it from peers.
Patel: "Rather than whatever we have earned, we have spent into new product line. So that is what makes difference between Meghmani and other companies."
China Plus One & Competitive Positioning
- China is pricing to destroy, but the strategy is unsustainable: China is keeping prices at very low levels to drive others out, with the intent to raise prices once competitors exit. Management called this unsustainable, and global customers, having realized the supply risk from China post-COVID, are prioritizing a second source for supply chain sustainability. India is the priority destination for that second source.
- Meghmani claims it can fight on price: The company has been export-oriented since 1995 and says it is capable of fighting against China in the pricing model even in the current situation. On synthetic pyrethroids specifically, management stated India is more competitive than China, with product being exported from India to China.
- Registrations are a durable moat: Customers will only buy from registered sources. In the current business environment, customers will not spend time or money adding new suppliers for old products, only for new products. This locks in existing relationships and raises the barrier for new entrants.
Patel: "Today, they want to reduce the price. They are keeping the price at very low level. Once everyone will be out, they may increase the price. So there is no sustainability."
New Product & Capacity Pipeline
- New product launches are a 1-2 year story: Flubendamide, Spiromesifen, Cyfluthrin, Beta Cyfluthrin, and Pymetrozine have been added in the last year. These will take 1-2 years to gain market share due to the registration timelines in different markets.
- Phase-II Crop Chem expansion is on ice: Capacity expansion for Phase-II has been kept on hold with no activity planned for the next one year. Basic infrastructure and environment clearance are ready, so the project can proceed very fast if the decision is taken, but the near-term focus is elsewhere.
- MPP utilization is at a trough, recovery expected: Multipurpose plant utilization was quite low in Q3, below 25%. This is expected to start improving from Q1 FY25 and should reach 50%+ from Q1 onwards.
- TiO2 is the nearer-term capacity fill: Utilization is expected to reach around 70% by the end of FY25. Customer approvals are expected to come very fast based on the company's experience in the pigment segment. The captive power plant commissioning in Q4 is the critical near-term catalyst for plant economics.
Nano-Urea: The Domestic Brand Pivot
- A strategic entry into a different game: The Nano-Urea project comes under Meghmani Crop Nutrition and marks the company's entry into the crop nutrition segment, which will also help it expand into the broader crop protection segment. This is the vehicle for increasing domestic market contribution to total revenue.
- The adoption challenge is real and behavioral: Farmers have used conventional Urea for many years and are difficult to convince to shift. IFFCO initially marketed the product incorrectly by linking it with conventional Urea, pushing without proper demonstration, and miscommunicating that it can replace Urea completely. The correct message is that Nano-Urea can only replace Urea partly.
- Demonstration is the unlock: Meghmani has conducted extensive field trials and is planning to arrange investor meetings where they can see results and meet farmers directly. Management believes that once farmers see results themselves, they will gradually shift.
- Government target likely delayed: The government's target to completely reduce Urea imports by 2025 will likely be delayed by one year to 2026, per management's analysis. By 2026, 0.9 crore tons of Urea is expected to be converted into Nano-Urea, with the remaining 2.5 crore tons shifting gradually thereafter as farmers get acquainted.
Patel: "Demonstration is the key area where the farmer needs to see the result by themselves. And once they will be satisfied with the result, then slowly, gradually they will be shifting."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Demand recovery begins | Export market demand starts improving | Q1 FY25 |
| Price recovery from bottom | Prices rise at least 5% to 10% from current bottom, after demand improves | After demand recovery begins; no specific quarter |
| TiO2 captive power plant | Commissioning completed | Q4 FY24 |
| TiO2 capacity utilization | Reach 70% capacity | Within two months (by end-Q4 FY24 / early Q1 FY25) |
| TiO2 capacity utilization | Reach ~70% by end of FY25 | FY25-end |
| MPP utilization improvement | Reach 50%+ utilization | From Q1 FY25 onwards |
| Phase-II Crop Chem expansion | No activity; project on hold | Next one year |
| Nano-Urea import reduction target | Government target to eliminate Urea imports | Delayed to 2026 (from 2025) |
| Nano-Urea conversion | 0.9 crore tons of Urea converted to Nano-Urea | By 2026 |
Key Metrics
| Metric | Q3 FY24 |
|---|---|
| Revenue | ₹345 cr, impacted by sluggish global demand and lower product price realization |
| EBITDA | Negative ₹0.4 cr |
| Crop protection revenue share | 69% of total revenue |
| Pigments revenue share | 31% of total revenue |
| Crop chem utilization | ~70% |
| Multipurpose plant utilization | Below 25% |
| TiO2 plant capacity utilization | 30–40%, expected to reach 70% in next two months |
| Pigment inventory | ~1.5 months of sales |
| Pigment pricing | Stabilized, no further reduction in selling price |
| Agrochemical price decline from peak | 45–50% on average across product range |
| 2,4-D price | Below $2/kg, down from ~$4 in good times |
| Expected price recovery from bottom | 5–10% increase, management view |
| Export revenue share | More than 85%, predominantly B2B |
| Red Sea logistics impact | 25–30 days increase in transit time |
| Nano-Urea import substitution target | 0.9 crore tons of urea imports to be replaced by 2026, per management analysis |